Compare Stocks → Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison TSE:COSNASDAQ:SBTXNYSE:TRX Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCOSCanadian Oil SandsC$0.00C$5.61▼C$13.87N/AN/A2.19 million shsN/ASBTXSilverback Therapeutics$9.18-0.6%$8.59$2.80▼$8.97$331.01M0.6337,931 shs477,153 shsTRXTRX Gold$0.46-3.2%$0.38$0.31▼$0.60$126.91M0.65343,575 shs779,809 shs13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceSBTXSilverback Therapeutics-0.65%-1.61%+0.22%+54.55%+41.45%TRXTRX Gold+14.87%+6.58%+21.46%+30.30%-10.95%The 1,000X Crypto Playbook (Ad)Chris Rowe has created a “Crypto Playbook” that anyone can follow… potentially turning small investments into pers#1 Crypto for 2024, completely FREE.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCOSCanadian Oil SandsN/AN/AN/AN/AN/AN/AN/AN/ASBTXSilverback TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ATRXTRX Gold3.0822 of 5 stars3.50.00.00.02.50.03.1Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCOSCanadian Oil SandsN/AN/AN/AN/ASBTXSilverback TherapeuticsN/AN/AN/AN/ATRXTRX Gold3.00Buy$1.58246.15% UpsideCurrent Analyst RatingsLatest SBTX, DEST, DDDD, TRX, and COS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/16/2024TRXTRX GoldAlliance Global PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$1.50 ➝ $1.754/16/2024TRXTRX GoldHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$1.30 ➝ $1.40(Data available from 4/17/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCOSCanadian Oil SandsN/AN/AN/AN/AN/AN/ASBTXSilverback TherapeuticsN/AN/AN/AN/A$7.41 per shareN/ATRXTRX Gold$38.32M3.31$0.01 per share31.65$0.23 per share1.98Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCOSCanadian Oil SandsN/AN/A0.00N/AN/AN/AN/AN/AN/ASBTXSilverback Therapeutics-$89.48M-$2.42N/A∞N/AN/A-29.62%-28.20%N/ATRXTRX Gold$2.25M$0.0145.556.50N/A0.70%-1.66%-1.18%4/18/2024 (Estimated)Latest SBTX, DEST, DDDD, TRX, and COS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/12/2024Q2 2024TRXTRX GoldN/A$0.01+$0.01N/A$9.40 million$7.98 million DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCOSCanadian Oil SandsN/AN/AN/AN/AN/ASBTXSilverback TherapeuticsN/AN/AN/AN/AN/ATRXTRX GoldN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCOSCanadian Oil SandsN/AN/AN/ASBTXSilverback TherapeuticsN/A67.8767.87TRXTRX GoldN/A0.930.61OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCOSCanadian Oil SandsN/ASBTXSilverback Therapeutics74.89%TRXTRX Gold1.06%Insider OwnershipCompanyInsider OwnershipCOSCanadian Oil SandsN/ASBTXSilverback Therapeutics34.40%TRXTRX Gold2.25%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCOSCanadian Oil Sands147,000N/AN/ANot OptionableSBTXSilverback Therapeutics8336.06 million23.65 millionNot OptionableTRXTRX Gold130278.92 million272.64 millionOptionableSBTX, DEST, DDDD, TRX, and COS HeadlinesSourceHeadlineRoth MKM Keeps Their Buy Rating on Tanzanian Royalty Exploration (TRX)markets.businessinsider.com - April 17 at 2:27 PMTRX Gold (NYSE:TRX) Price Target Increased to $1.75 by Analysts at Alliance Global Partnersamericanbankingnews.com - April 17 at 4:36 AMTRX Gold (NYSE:TRX) Price Target Increased to $1.40 by Analysts at HC Wainwrightamericanbankingnews.com - April 17 at 3:48 AMTRX Gold (NYSE:TRX) Receives New Coverage from Analysts at StockNews.comamericanbankingnews.com - April 17 at 2:14 AMBuy Rating Affirmed for Tanzanian Royalty Exploration Amid Strong Financials and Operational Advancementsmarkets.businessinsider.com - April 16 at 2:03 PMTRX Gold (NYSE:TRX) PT Raised to $1.75 at Alliance Global Partnersmarketbeat.com - April 16 at 1:28 PMTRX Gold nears completion of plant expansion at Buckreef gold projectproactiveinvestors.com - April 15 at 8:42 AMTRX Gold Corporation: TRX Gold Expects Significant Growth with Plant Expansion Nearing Completionfinanznachrichten.de - April 15 at 7:59 AMTRX Gold (NYSE:TRX) Issues Earnings Resultsamericanbankingnews.com - April 15 at 7:08 AMTRX Gold Expects Significant Growth with Plant Expansion Nearing Completionglobenewswire.com - April 15 at 6:30 AMCrypto Whale Incoming: Tron (TRX) And Litecoin (LTC) Exceed Expectations, Whilst Scorpion Casino (SCORP) Nears Its Official Launchoutlookindia.com - April 13 at 7:45 AMTRX Stock Earnings: TRX Gold Misses Revenue for Q2 2024markets.businessinsider.com - April 12 at 11:24 PMBlockDAG Presale Triumph: Eyeing $10 Value With 20,000x ROI Amidst TRON’s Decline And Upcoming Bitcoin Halvingfinbold.com - April 12 at 8:21 AMTRON Sees Whale Outflows; Bonk Aims For New ATH; NuggetRush Becomes Retail Favoritefinbold.com - April 10 at 8:42 AMTRX Gold (NYSE:TRX) Coverage Initiated at StockNews.comamericanbankingnews.com - April 9 at 2:20 AMNuggetRush’s Presale Sparks Interest Over WIF and TRON Predictable Playsmsn.com - April 7 at 1:09 PMTRX Gold Reports 2023 Annual Meeting Voting Resultsglobenewswire.com - April 5 at 4:05 PMTechnology and transition in agricultureocj.com - April 4 at 6:14 PMNew things to do in Kuala Lumpur in 2024thesmartlocal.com - April 4 at 9:21 AMStep into the most expensive and luxurious cinemas around the globemsn.com - April 3 at 12:10 PMBuckreef pays 13bn/- as taxes, fees to govtdailynews.co.tz - April 3 at 7:09 AMBeauty Buys: 10 products on our radar for April 2024lifestyleasia.com - April 2 at 10:38 AMReport: Iran warned Russia about terrorist threat before Moscow attackmsn.com - April 1 at 3:22 PMTRX Emerges as Malaysia's International Financial Centre and KL’s Social Heartastroawani.com - April 1 at 9:57 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioFoot Locker Builds Up Another Head of Steam; Gains ImminentMarch 28, 2024 10:58 AMView Foot Locker Builds Up Another Head of Steam; Gains Imminent5 Stocks in the Current Bull Market with Upside to ComeApril 5, 2024 10:14 AMView 5 Stocks in the Current Bull Market with Upside to Come5 Top-Rated Dividend Stocks With Double-Digit UpsideMarch 25, 2024 11:19 AMView 5 Top-Rated Dividend Stocks With Double-Digit UpsideBiotech Sector Nears Breakout: Will it Outperform in Q2?April 3, 2024 6:10 AMView Biotech Sector Nears Breakout: Will it Outperform in Q2?All Headlines Company DescriptionsCanadian Oil SandsTSE:COSCanadian Oil Sands Limited is a Canada-based investment company. The Company owns a 36.74% interest in the Syncrude Joint Venture (Syncrude), a producer of low sulphur, light, synthetic crude oil (SCO). Syncrude is involved in the mining and upgrading of bitumen from oil sands near Fort McMurray in northern Alberta. The Syncrude Project is comprised of open-pit oil sands mines, utilities plants, bitumen extraction plants and an upgrading complex that processes bitumen into SCO. Syncrude's leases are located in the Athabasca oil sands deposit. Syncrude produces SCO by mining oil sands, extracting the bitumen from the sands, upgrading the recovered bitumen into lighter oil fractions and combining those fractions into a single SCO product.Silverback TherapeuticsNASDAQ:SBTXSilverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.TRX GoldNYSE:TRXTRX Gold Corporation engages in the exploration, development, and production of mineral property interests in the United Republic of Tanzania. The company primarily explores for gold deposits. It holds interests in the Buckreef gold project that comprises a single Special Mining License covering an area of 16.04 square kilometers and 12 Prospecting Licenses covering 98.19 square kilometers located in north-central Tanzania. The company was formerly known as Tanzanian Gold Corporation and changed its name to TRX Gold Corporation in May 2022. TRX Gold Corporation was incorporated in 1990 and is based in Oakville, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.